Manager × security

Tejara Capital Ltd ARQT holdings history

Who else holds this security? →

ARCUTIS BIOTHERAPEUTICS INC · CUSIP 03969K108 · CIK 1879713

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Tejara Capital Ltd reported 113.08K ARQT (shares), valued at $2.97M, or 1.22% of its reported non-derivative portfolio. Filed 2026-08-11.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
1.22%
Shares
113.08K
113,084
Reported value
$2.97M
USD

Shares decreased 31.96%; reported value decreased 24.27%, and weight changed -0.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20261.22%113,084SEC filing ↗Filed Aug 11, 2026
Q1 20261.29%166,191SEC filing ↗Filed May 12, 2026
Q4 2025Not reportedNot reported—
Q3 20255.38%520,503SEC filing ↗Filed Nov 4, 2025
Q2 20255.68%873,381SEC filing ↗Filed Aug 13, 2025
Q1 20256.52%846,221SEC filing ↗Filed May 13, 2025
Q4 20248.10%886,838SEC filing ↗Filed Feb 10, 2025
Q3 20245.17%1,165,309SEC filing ↗Filed Nov 13, 2024
Q2 20244.55%1,343,609SEC filing ↗Filed Aug 14, 2024
Q1 20243.45%940,487SEC filing ↗Filed May 14, 2024
Q4 20231.50%1,112,217SEC filing ↗Filed Feb 12, 2024
Q3 20230.93%309,179SEC filing ↗Filed Nov 15, 2023Amended

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20230.93%309,179$1.64MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Nov 15, 2023
Q4 20231.50%1,112,217$3.59MShares increased 259.73%; reported value increased 118.82%, and weight changed +0.57 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 12, 2024
Q1 20243.45%940,487$9.32MShares decreased 15.44%; reported value increased 159.44%, and weight changed +1.95 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 14, 2024
Q2 20244.55%1,343,609$12.50MShares increased 42.86%; reported value increased 34.07%, and weight changed +1.10 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20245.17%1,165,309$10.84MShares decreased 13.27%; reported value decreased 13.27%, and weight changed +0.62 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 13, 2024
Q4 20248.10%886,838$12.35MShares decreased 23.90%; reported value increased 13.99%, and weight changed +2.93 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 10, 2025
Q1 20256.52%846,221$13.23MShares decreased 4.58%; reported value increased 7.13%, and weight changed -1.58 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 13, 2025
Q2 20255.68%873,381$12.24MShares increased 3.21%; reported value decreased 7.48%, and weight changed -0.84 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 13, 2025
Q3 20255.38%520,503$9.81MShares decreased 40.40%; reported value decreased 19.87%, and weight changed -0.30 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 4, 2025
Q4 2025Not reported——This security is absent from this quarter's filing; a missing record is not treated as zero holdings.—
Q1 20261.29%166,191$3.92MA comparable prior-quarter record is unavailable; changes are not inferred.SEC filing ↗
Filed May 12, 2026
Q2 20261.22%113,084$2.97MShares decreased 31.96%; reported value decreased 24.27%, and weight changed -0.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 11, 2026
Tejara Capital Ltd · ARCUTIS BIOTHERAPEUTICS INC

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1879713","quarter":"2026Q2","cusip":"03969K108"}

get_institutional_manager_history
{"cik":"1879713","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.